1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 08 FEBRUARY 2016

Cancer Drug News 08 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Oncology Performance Validates Strong Focus
Industry Brief - Immunomedics' Sacituzumab Govitecan Gains FDA Breakthrough Therapy Designation For TNBC
Industry Trend Analysis - Direct Jakafi Competition Prospects In Myelofibrosis Waning
Industry Brief - Seattle Receives Adcetris Milestone Payment From Takeda
Industry Brief - ST Asia To Distribute PharmaMar's Aplidin In Asia-Pacific
Industry Brief - OSE Pharma Initiates US Phase III Study Of Tedopi In NSCLC
Industry Brief - Tagrisso Approved In EU
Industry Brief - ImmunoGen/Merck Enter Clinical Research Collaboration In OC
Industry Brief - TapImmune Granted Fast Track Designation For Lead Cancer Vaccine
Industry Brief - Opdivo Phase III SCCHN Trial Stopped Early Following Favourable Results
Industry Brief - MedinCell/Sandoz Collaborate To Develop Long-Acting Injectable Products
Industry Trend Analysis - GSK Making Gains In Customising Novel Oncology Division
Industry Brief - Mersana/Takeda Expand ACD Partnership
Industry Brief - Eagle Launches Alcohol-Free Docetaxel
Industry Brief - AstraZeneca Completes Majority Equity Stake Purchase Of Acerta
Industry Trend Analysis - NGS Portfolio Development To Benefit Diagnostics And Pharmaceuticals

Table Of Contents

Cancer Drug News 08 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.